Relugolix
Catalog No. A17783
Relugolix is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist with IC50 of 0.33 nM in the presence of 40% fetal bovine serum, TAK-385 possesses higher affinity and potent antagonistic activity compared with TAK-013.
| Catalog Num | A17783 |
|---|---|
| M. Wt | 623.63 |
| Formula | C29H27F2N7O5S |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 737789-87-6 |
| Synonyms | TAK385; TAK-385; TAK 385; Relugolix. |
| SMILES | O=C(NOC)NC1=CC=C(C(S2)=C(CN(C)C)C(C(N3C4=NN=C(OC)C=C4)=O)=C2N(CC5=C(F)C=CC=C5F)C3=O)C=C1 |
Relugolix is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist with IC50 of 0.33 nM in the presence of 40% fetal bovine serum, TAK-385 possesses higher affinity and potent antagonistic activity compared with TAK-013.
| In vitro | DMSO | 59 mg/mL (94.6 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 16.04 mL | 80.18 mL | 160.35 mL |
| 0.5 mM | 3.21 mL | 16.04 mL | 32.07 mL |
| 1 mM | 1.6 mL | 8.02 mL | 16.04 mL |
| 5 mM | 0.32 mL | 1.6 mL | 3.21 mL |
*The above data is based on the productmolecular weight 623.63. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.